No description available.

Submitted by Hiolanda Rêgo (hiolandarego@gmail.com) on 2017-11-09T15:57:04Z No. of bitstreams: 1 Dissertação_ODONTO_ Ernesto Santos Sousa Neto.pdf: 4765427 bytes, checksum: ae3f93ce46ff32b7ce466869740090de (MD5) / Approved for entry into archive by Delba Rosa (delba@ufba.br) on 2017-11-17T14:44:34Z (GMT) No. of bitstreams: 1 Dissertação_ODONTO_ Ernesto Santos Sousa Neto.pdf: 4765427 bytes, checksum: ae3f93ce46ff32b7ce466869740090de (MD5) / Made available in DSpace on 2017-11-17T14:44:34Z (GMT). No. of bitstreams: 1 Dissertação_ODONTO_ Ernesto Santos Sousa Neto.pdf: 4765427 bytes, checksum: ae3f93ce46ff32b7ce466869740090de (MD5) / Fapesb / O presente trabalho teve como objetivo estudar, por meio da imunohistoquímica, a participação de componentes celulares estromais a exemplo dos mastócitos (mast cell triptase), miofibroblastos (alfa-SMA) e macrófagos (CD163) e componentes vasculares (CD34 e D2-40) em uma série de tumores odontogênicos queratocísticos (TOQ), na tentativa de fornecer subsídios para compreender a interação entre esses componentes e o comportamento biológico distinto desta lesão. Para fins comparativos, cistos radiculares (CRs) e folículos pericoronários (FPs) também foram incluídos. A amostra foi composta por 30 TOQs, 15 CRs e 07 FPs. Para a avaliação dos mastócitos, miofibroblastos e macrófagos, foram quantificadas as células imunorreativas aos marcadores mast cell triptase, alfa-SMA e CD163, respectivamente, em 10 campos (400x). Os índices angiogênico e linfangiogênico foram avaliados por meio da densidade microvascular (MVD) e densidade microvascular linfática (MVDL) dos microvasos marcados, respectivamente, pelos marcadores CD34 e D2- 40. Foi utilizado o teste ANOVA com pós-teste de correção de Tukey, para análise estatística entre os marcadores segundo o tipo de lesão. Para a análise da correlação entre os marcadores dentro da mesma lesão, utilizamos a correlação de Pearson. Para a associação, no TOQ, entre os marcadores e a presença de inflamação, utilizamos o Teste T de Student. A análise da expressão do marcador mast cell triptase revelou existir diferenças significativas (p<0,05) entre a densidade de células mastocitárias presentes nos CRs (22,7) em relação aos FPs (1,23) e TOQs (7,39), e entre a densidade de mastócitos presentes no TOQs e FPs. Houve também diferença significativa (P<0,05) entre a densidade de miofibroblastos em TOQs (29,25) em relação aos CRs (4,66) e os FPs (1,50). A diferença da densidade de miofibroblastos entre os CRs e FPs não foi significativa (p>0,05). A respeito dos macrófagos, não houve diferenças significativas (p= 0,084) entre as densidades de macrófagos presentes nos TOQs (2,31), CRs (1,42) e FPs (0,14). Na avaliação do índice angiogênico, não houve diferenças significativas da MVD entre as três lesões estudadas. No entanto, para o índice linfangiogênico, houve diferença significativa (p<0,05) entre a MVDL presentes nos TOQs (11,64) em relação aos CRs (4,19) e aos FPs (0,167). A diferença entre a MVDL dos CRs em relação aos FPs não foi estatisticamente significante (p>0,05). Não foi encontrada associação significativa (p>0,05) entre os marcadores estudados com a presença de inflamação no TOQ. No presente trabalho, encontramos uma correlação positiva e moderada entre os marcadores mast cell triptase e o CD34 nos TOQ (p = 0,025). Já nos CRs encontramos uma correlação inversa e moderada entre os marcadores SMA x CD34 (p = 0,017). Nos FPs também encontramos uma correlação inversa entre os mesmos marcadores anteriores, porém forte (p=0,049). Embora os componentes celulares estromais e microvasculares aqui representados por mastócitos, miofibroblastos, macrófagos CD163 positivos e vasos CD34 e D240, respectivamente, sejam importantes para manutenção do arcabouço estrutural do TOQ e CR, existiu uma interação significante entre mast cell triptase e CD34 no TOQ e entre CD34 e o alfa –SMA no CR.

No description available.

Background: Intestinal inflammation elicited by environmental determinants including dietary proteins and microbes is implicated in type 1 diabetes (T1D) pathogenesis. Also, intrinsic pancreatic abnormalities could precede classic insulitis, contributing to T1D. Materials and Methods: Spontaneous rat T1D models were used for in situ analyses of gut and pancreas to explore novel disease pathways using immunohistochemistry and detailed morphometry, gene expression studies, and molecular screening analyses. Results: In BBdp rats, feeding a cereal diet stimulated T1D under germ-free or specific pathogen-free (SPF) conditions compared with a protective hydrolyzed casein (HC) diet. Cereal-induced T1D was paralleled by increased gut T cell infiltration and TH1-associated pro-inflammatory transcription. HC-fed rats displayed an increased number of anti-inflammatory CD163+ M2 macrophages compared with cereal-fed rats. Cereal-associated promotion of T1D in Lewis diabetes-prone (LEW-DP) rats, a different rat model, similarly featured gut T cell infiltration in conjunction with decreased immunoregulation. The Camp gene was induced in diet-protected HC-fed BBdp rats. Camp encodes the cathelicidin antimicrobial peptide (CAMP), a pleiotropic immunomodulatory host defence factor. Intestinal CAMP was enriched in CD163+ M2 macrophages and could represent a novel marker of these tolerogenic innate immune cells. CAMP expression was also discovered in pancreatic lymph nodes (PLN) and islets, indicating a novel role for this factor in target tissue homeostasis. There was a positive correlation between pancreatic CAMP and total islet number. Also, islet-associated CAMP+ cells were increased in rats with islet inflammation, suggesting upregulation in parallel with insulitis. Exogenous CAMP/LL-37 injections increased the abundance of T1D-protective probiotic bacteria and promoted islet neogenesis in BBdp rats. A prospective partial pancreatectomy (PPx) study was performed to obtain pre-diabetic pancreas biopsies from iii pre-insulitic BBdp rats. The number of endothelium-associated CD68+ macrophages was increased in pre-diabetic pancreata, indicating that perivascular inflammation was an early lesion in the animals. In addition, pre-diabetic pancreata featured enhanced regenerative Reg3a and Reg3b gene expression, indicating abnormal islet expansion preceding insulitis. Conclusions: Small intestinal inflammation paired with deficits in local immunoregulation parallels T1D development. CAMP represents a novel factor in T1D that could have several pleiotropic functions including regulation of commensal microbes, intestinal homeostasis, and pancreatic homeostasis. In addition, target tissue abnormalities precede insulitis and T1D. This research focused on the integrative biology of T1D pathogenesis in spontaneous rat models. This work provides a novel working model that incorporates key roles for gut lumen antigens, intestinal immunity, and the role of islets and altered regenerative capacity in T1D. This research could lead to new therapeutic opportunities for T1D treatment.

<p dir="ltr">Porcine reproductive and respiratory syndrome virus (PRRSV) is a devastating virus that is endemic to the swine industry. This virus has little direct effect on the dam but results in abortions, stillborn, and delivery of viremic piglets. PRRSV is unable to cross the swine placenta in early gestation but as gestation progresses, the placenta becomes permissible during late gestation. The mechanisms that allow the virus to cross the late gestation placenta are not well understood, but several theories have been presented regarding changes in placental morphology or enzymatic changes. Additionally, piglets who experience IUGR due to uterine crowding have been found to be more resistant to PRRSV infection, having lower viral levels than their normal litter mates. When vertical transmission from the dam to fetus occurs not only can the effects previously mentioned occur, but PRRSV is also known to cause suppression of maternal and fetal thyroid hormone. Thyroid hormone plays numerous roles in fetal development such as accretion of fetal mass, appetite regulation, and coincidently follows a similar increase trajectory to that of fetal growth during mid- to late-gestation. Consequently, any dysregulation of thyroid hormone has the potential to cause severe side-effects and may alter fetal growth. The relationship between thyroid hormone and fetal growth and development is not well understood. Chapter 2 investigates the potential cause-and-effect relationship between fetal growth and thyroid hormone through the induction of fetal hypothyroidism. Pregnant gilts (n=24) were given a sham treatment (CON; n=12) or treated with methimazole (MMI; n=12), a goitrogen capable of crossing the placenta. These gilts were then further subdivided across four gestational timepoints spanning mid- to late-gestation, these being days 55, 66, 76, and 86. Treatment started 21 days prior to these desired dates. Upon completion of treatment the gilts were humanely euthanized, and fetuses were extracted (resulting populations of n=174 MMI and n=166 CON) and fetal body and organ weights were recorded. Collected tissues included heart, liver, lung, kidneys, spleen, brain and thyroid. Fetuses were imaged in the left and right lateral recumbency for phenotypic analysis, including novel head measurements. Placental sample were also taken. Additionally fore- and hind limbs were taken from the centermost male and female from each litter so that radiographs could be taken to analyze bone growth. Statistical analysis of all phenotypic differences was carried out using a linear mixed effect model including gestational age and treatment as fixed effects and gilt as a random effect. The data revealed that the left and right phenotypic parameters are highly correlated (R2>0.9). Upon extraction, goiters were present in the MMI fetuses and there was a significant increase in both absolute and relative thyroid weights. Thus, the use of MMI during this period of gestation was successful in inducing hypothyroidism. Additionally, the MMI treated thyroids had a significant treatment by time interaction with 0.014g and 0.21g increase at day 55 and 66 respectively indicating reduced compensatory action within the fetal hypothalamic-pituitary-thyroid axis during this earliest period. Liver weight as a percentage of body weight decreased from 6.06% to 2.56% between days 55 and 86 in the CON group but, was significantly increased at all time points in response to MMI induced hypothyroidism (P<0.01). Thus, the in brain to liver weight ratio decreases over time, in MMI fetuses (P<0.05). While all other phenotypic parameters were significantly altered by gestation age, there was no significant impact of fetal hypothyroidism. This indicates that fetal thyroid hormone is not the driving factor for the exponential fetal growth seen in mid- to late-gestation. PRRSV virus is a complex and devastating virus to the swine industry, especially when it infects pregnant gilts and sows. PRRSV is unable to cross the swine placenta during mid-gestation but as gestation progresses the virus readily crosses the placenta and is able to infect piglets during this late gestation period. The mechanisms by which PRRSV crosses the highly restrictive porcine placenta are not clear. Additionally, piglets who experience intrauterine growth retardation experience lower virus levels than their normal counterparts. Chapter 3 investigates the changes in three genes of interest that we hypothesized, had the potential to fluctuate throughout gestation and facilitate PRRSV transfer, as well as the morphological changes that occur in the maternal-fetal interface through mid- to late-gestation and how these aspects may vary between IUGR and normal piglets. Placental samples were collected from pregnant gilts (n=12) equally divided across days 55, 66, 76, and 86 of gestation. Samples were taken of each fetus’s placenta adjacent to the umbilical cord. A portion of the sample was cut into 1 cm2 and placed into a mold with optimal cutting temperature media (OCT) for later cryo-sectioning and histology. The remaining portion had the fetal placenta peeled from the endometrium and flash frozen in liquid nitrogen for RNA extraction. A subset of samples was chosen based on fetus’s brain to liver weight ratios (n=96). From each litter two males and two females with the most extreme case of IUGR, based on z-scores, were chosen and the same was done for the two males and females with lowest brain to liver weight ratios, the later were classified as large for gestational age (LGA). 56 of the original 64 had acceptable levels of placental RNA for analysis. A total of 3 genes were chosen for analysis based on their function and previous literature. These included CD163, SIGLEC1 and IL-10. No significant up or down regulation was seen in any of the selected genes and there was no variation between IUGR and LGA fetuses. Additionally, placenta histology was conducted to evaluate populations of CD163 positive macrophages throughout the maternal fetal interface across mid- to late-gestation. Populations of CD163 positive macrophages were found on both the maternal and fetal sides of the maternal fetal interface at all timepoints. Collectively these results show there is no fluctuation in CD163, SIGLEC1, or IL-10 among timepoints or between IUGR and LGA fetuses. Additionally, the histology samples confirm the presence of resident populations of CD163 positive macrophages on maternal and fetal sides of the MFI. Collectively these results indicate that more research needs to be done to determine the underlying mechanisms of PRRSV transmission during late gestation.</p>